Related Experiment Video
Updated: Jan 11, 2026
Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and Horos
Published on: March 21, 2021
Is Appendicular Lean Soft Tissue Mass a Clinically Valid Diagnostic Marker for Sarcopenia?
Yosuke Osuka1,2, Sho Hatanaka2, Narumi Kojima2
1Department of Frailty Research, Center for Gerontology and Social Science, Research Institute, National Center for Geriatrics and Gerontology, Obu, Aichi, Japan.
Aim:
Geriatric experts have long debated the inclusion of appendicular lean soft tissue mass (ALSTM) in the diagnostic criteria for sarcopenia. This study examined whether a diagnostic model for sarcopenia that excludes appendicular lean soft tissue mass (ALSTM) is equivalent to one that includes ALSTM in discriminating health-related outcomes.
Methods:
Community-dwelling older adults from the Itabashi Longitudinal Study on Aging in Tokyo, Japan, were included. Based on the AWGS2019 criteria, we developed two diagnostic models: Model 1, including low handgrip strength/gait speed and low ALSTM assessed by bioelectrical impedance analysis, and Model 2, excluding low ALSTM. Health-related outcomes were self-reported falls and hospitalization in the past year. Differences in area under the receiver operating characteristic curve (AUC) and 95% confidence intervals (CI) between the two models were estimated using 1000 bootstrap samples.
Results:
In total, 2432 participants (median age: 76 years; 53.2% men) without missing data were analyzed. Falls and hospitalization were reported by 17.8% and 15.3% of participants, respectively. The AUCs [95% CIs] of Models 1 and 2 were 0.61 [0.59, 0.64] and 0.61 [0.58, 0.64] for falls and 0.65 [0.62, 0.68] and 0.64 [0.61, 0.67] for hospitalization, respectively. The differences (Model 2-Model 1) in AUCs [95% CI] between the two models were -0.004 [-0.015, 0.006] for falls and -0.004 [-0.014, 0.004] for hospitalization, with the CIs within the pre-specified equivalence margin (±0.05).
Conclusions:
Diagnostic models excluding ALSTM demonstrated equivalent discrimination ability to those including ALSTM, raising questions about the necessity of ALSTM assessment for sarcopenia diagnosis.
